Welcome

AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.

Events

11/24/2021 | European innovation Summit 2021
Arromics will participate at the new European Innovation Council, launched in... More

11/02/2021 | Aromics at Virtual health sector disruption tour to Silicon Valley and New York
Aromics is one of the companies participating in the new virtual disruptour... More

News

11/25/2021 | Aromics one of the companies pitching at #EICSummit2021
The new European Innovation Council, launched in March 2021, is holding this... More

05/13/2021 | AROMICS among the top 40 companies to invest in Europe
InvestHorizon is a programme financed by the European Commission, in association... More